Honey is not a free pass for people with diabetes, but it’s not off-limits either. With a glycemic index of 58, honey raises blood sugar slightly less than table sugar (GI of 60), and small amounts may even offer modest metabolic benefits. The key is quantity: clinical trials suggest that about half a tablespoon (10 grams) per day, used as a replacement for other added sugars, is the sweet spot. Beyond that, the risks start to outweigh the benefits.
How Honey Compares to Table Sugar
Honey is roughly 40% fructose and 27% glucose, with the rest being water and trace compounds. Table sugar, by contrast, is a clean 50/50 split of fructose and glucose. That higher fructose ratio matters because fructose has a glycemic index of just 19, compared to 100 for pure glucose. This is why honey produces a slightly lower blood sugar spike than the same amount of table sugar, both in people with diabetes and in those without.
That said, “slightly lower” is doing a lot of work in that sentence. A GI of 58 versus 60 is not a meaningful difference for most people managing their blood sugar day to day. Honey is still a concentrated source of simple sugars, and your body processes most of it the same way it processes any other sweetener. The American Diabetes Association classifies honey alongside syrups, table sugar, and corn syrup as an added sugar.
What Clinical Trials Actually Show
A large meta-analysis pooling 69 randomized controlled trials with over 3,500 participants found that 10 grams of honey per day (roughly half a tablespoon) was associated with a small but real reduction in HbA1c, the marker that reflects average blood sugar over two to three months. The reduction was modest, about 0.37 percentage points, but that’s in the range that clinicians consider meaningful for a single dietary change.
Here’s the catch: the same analysis found that honey intake actually raised fasting blood glucose levels, especially with long-term use. So honey may improve the long-term average while still causing sharper individual spikes. The benefit also faded at higher doses. At 50 grams per day (about 2.5 tablespoons), the HbA1c improvement essentially disappeared. More honey did not mean more benefit.
The researchers also flagged concerns about triglycerides, liver enzyme levels, blood pressure, and inflammatory markers with longer-term honey consumption. The overall quality of evidence was rated very low, meaning these findings should be taken as suggestive rather than definitive.
Honey’s Antioxidants and Insulin Sensitivity
What separates honey from plain sugar is its antioxidant content. Honey contains dozens of plant-based compounds, including flavonoids like quercetin, kaempferol, and chrysin, along with various phenolic acids. These compounds act as free radical scavengers, reducing the kind of cellular damage (oxidative stress) that can impair the way your body responds to insulin.
In lab and animal studies, these antioxidants have been shown to help restore insulin signaling pathways that oxidative stress disrupts. Some research has also documented reductions in fructosamine (another marker of blood sugar control) and glycosylated hemoglobin with honey consumption. This likely explains the paradox of honey showing some metabolic benefits despite being, at its core, a sugar. The antioxidant compounds partially counteract the damage the sugars themselves cause.
Darker honeys, such as buckwheat and manuka varieties, tend to contain higher concentrations of these phenolic compounds than lighter commercial blends. However, no clinical trials have directly compared different honey types for blood sugar management in people with diabetes, so the practical advantage of choosing one variety over another remains unclear.
The Fructose Problem
Honey’s high fructose content is a double-edged sword. Fructose keeps the glycemic index lower, but your liver processes nearly all of it, and excess fructose activates genes involved in fat production. Animal research has shown that high fructose intake from honey increased insulin resistance and activated the same fat-building genetic pathways as synthetic high-fructose solutions. The one reassuring finding: honey did not elevate liver enzymes the way pure fructose solutions did, and liver tissue showed no visible fatty changes. So honey appears gentler on the liver than equivalent amounts of isolated fructose, possibly because its antioxidants provide some protection.
Still, for someone with diabetes who already has concerns about insulin resistance, triglycerides, or fatty liver, the fructose load from generous honey consumption is a legitimate risk.
How Much Honey Is Reasonable
Based on the available evidence, the practical guideline is straightforward. If you want to use honey, treat it as a direct replacement for other added sugars, not an addition to them. The strongest benefits in clinical trials appeared at around 10 grams per day, which is roughly half a tablespoon or one teaspoon. At that dose, you’re getting some antioxidant benefit without overwhelming your blood sugar management.
A few things to keep in mind:
- Count it in your carbs. One tablespoon of honey contains about 17 grams of carbohydrates. That needs to be factored into your meal planning the same way any other carb source would.
- Swap, don’t add. The benefits seen in trials came from replacing other sugars with honey, not from adding honey on top of existing sugar intake.
- Watch your portions. Honey is easy to over-pour. Measuring it rather than drizzling freely helps keep intake in the range where the research shows benefit rather than harm.
- Monitor your response. Individual blood sugar responses to honey vary widely. Checking your glucose after eating honey a few times will tell you more about your personal tolerance than any study average can.
The American Diabetes Association doesn’t single out honey as better or worse than other sweeteners. Their guidance encourages people to find what works for them, whether that’s small amounts of natural sugars like honey or maple syrup, or non-nutritive sweeteners like stevia or monk fruit. Honey is one option among several, not a treatment for diabetes.